2012-02-11 04:04:22 - New Medical Devices research report from Global Markets Direct is now available from Fast Market Research

Finland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017

Summary

"Finland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017", a new report by Global Markets Direct, provides key market data on the Finland In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and

secondary research and in-house analysis by Global Markets Direct's team of industry experts.


Full Report Details at
- www.fastmr.com/prod/330082_finland_in_vitro_diagnostics_investme ..


Scope

* Market size and company share data for In Vitro Diagnostics market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
* Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
* 2010 company shares and distribution shares data for each of the seven market categories.
* Global corporate-level profiles of key companies operating within the Finland In Vitro Diagnostics market.
* Key players covered include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthcare, Beckman Coulter, Inc., bioMerieux S.A., Ortho-Clinical Diagnostics Inc. and others.

Reasons to buy

* Develop business strategies by identifying the key market categories and segments poised for strong growth.
* Develop market-entry and market expansion strategies.
* Design competition strategies by identifying who-stands-where in the Finland In Vitro Diagnostics competitive landscape.
* Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
* What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned in this Report: F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthcare, Beckman Coulter, Inc., bioMerieux S.A., Ortho-Clinical Diagnostics Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Sysmex Corporation, Phadia AB, DiaSorin S.p.A, Qiagen N.V., Ani Labsystems Ltd Oy, PerkinElmer, Inc., DIAGNOSTICA STAGO, Inc., Thermo Fisher Scientific Inc., Gen-Probe Incorporated, HORIBA, Ltd., Grifols, S.A., Life Technologies Corporation, Cellestis Limited, Hologic, Inc., Immucor, Inc., Danaher Corporation

Partial Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 In Vitro Diagnostics In Finland
3.1 In Vitro Diagnostics, Finland, Overall Revenue ($m), USD Actual, 2003-2017
3.2 In Vitro Diagnostics, Finland, Company share (2009-2010)
4 Clinical Chemistry In Finland
4.1 Clinical Chemistry Overall Revenue (2003-2017)
4.1.1 Clinical Chemisty Analyzers Revenue (2003-2017)
4.1.2 Urine Analysis Revenue (2003-2017)
4.2 Clinical Chemistry Distribution Share (2009-2010)
4.3 Clinical Chemistry, Finland, Company share (2009-2010)
5 Genetic Testing In Finland
5.1 Genetic Testing Overall Revenue (2003-2017)
5.2 Genetic Testing Distribution Share (2009-2010)
5.3 Genetic Testing, Finland, Company share (2009-2010)
6 Haematology In Finland
6.1 Haematology Overall Revenue (2003-2017)
6.1.1 Haematology Reagents Revenue (2003-2017)
6.1.2 Immunohaematology Revenue (2003-2017)
6.1.3 Haemostasis Revenue (2003-2017)
6.1.4 Haematology Rapid Tests Revenue (2003-2017)
6.1.5 Haematology Cell Counters Revenue (2003-2017)
6.2 Haematology Distribution Share (2009-2010)
6.3 Haematology, Finland, Company share (2009-2010)
7 Histology And Cytology In Finland
7.1 Histology And Cytology Overall Revenue (2003-2017)
7.2 Histology And Cytology Distribution Share (2009-2010)
7.3 Histology And Cytology, Finland, Company share (2009-2010)
8 Immuno Chemistry In Finland
8.1 Immuno Chemistry Overall Revenue (2003-2017)
8.1.1 Disease Specific Immunochemistry Revenue (2003-2017)
8.1.2 Drugs of Abuse / Toxicology Revenue (2003-2017)
8.1.3 Endocrinology Tests Revenue (2003-2017)
8.1.4 Therapeutic Drug Monitoring Revenue (2003-2017)
8.1.5 Immunochemistry Analyzers Revenue (2003-2017)
8.2 Immuno Chemistry Distribution Share (2009-2010)
8.3 Immuno Chemistry, Finland, Company share (2009-2010)
9 Infectious Immunology In Finland
9.1 Infectious Immunology Overall Revenue (2003-2017)
9.2 Infectious Immunology Distribution Share (2009-2010)
9.3 Infectious Immunology, Finland, Company share (2009-2010)
10 Microbiology Culture In Finland
10.1 Microbiology Culture Overall Revenue (2003-2017)
10.1.1 Microbiology Analyzers Revenue (2003-2017)
10.2 Microbiology Culture Distribution Share (2009-2010)

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=330082&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.